Cargando…
A Novel Tongue Squamous Cell Carcinoma Cell Line Escapes from Immune Recognition due to Genetic Alterations in HLA Class I Complex
Immune checkpoint inhibitors (ICI) have made progress in the field of anticancer treatment, but a certain number of PD-L1 negative OSCC patients still have limited benefits from ICI immuno-therapy because of primary immune evasion due to immunodeficiency. However, in existing human OSCC cell lines,...
Autores principales: | Zheng, Xiaofeng, Sun, Yanan, Li, Yiwei, Ma, Jiyuan, Lv, Yinan, Hu, Yaying, Zhou, Yi, Zhang, Jiali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818362/ https://www.ncbi.nlm.nih.gov/pubmed/36611830 http://dx.doi.org/10.3390/cells12010035 |
Ejemplares similares
-
Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule
Publicado: (1990) -
HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses
por: Erdmann, Nathan, et al.
Publicado: (2015) -
Transcriptomic dissection of tongue squamous cell carcinoma
por: Ye, Hui, et al.
Publicado: (2008) -
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
por: Garrido, Federico, et al.
Publicado: (2017) -
Landscape of antitumor CD4(+) T cells in melanoma:unraveling novel HLA class II-driven immune escape
por: Xue, Xiangjie, et al.
Publicado: (2023)